Potentially high and aberrantly glycosylated ACE2 in the lung, nasal airways, tongue, and oropharynx in uncontrolled hyperglycemia could also serve as increased SARS‐CoV‐2 viral binding sites, thus leading to a higher propensity to COVID‐19 infection and a higher disease severity. The gene discussed is ACE2; the disease is Hyperglycemia.